The discovery of a novel series of compounds with single-dose efficacy against juvenile and adult Schistosoma species. (2021)
Attributed to:
Identification of a novel oral clinical candidate superior to praziquantel to treat schistosomiasis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pntd.0009490
PubMed Identifier: 34280206
Publication URI: http://europepmc.org/abstract/MED/34280206
Type: Journal Article/Review
Volume: 15
Parent Publication: PLoS neglected tropical diseases
Issue: 7
ISSN: 1935-2727